These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 22418998

  • 1. Osmotic pellet system comprising osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug.
    Saindane N, Vavia P.
    J Pharm Sci; 2012 Sep; 101(9):3169-79. PubMed ID: 22418998
    [Abstract] [Full Text] [Related]

  • 2. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
    Ige PP, Gattani SG.
    Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH, Taha NF, Badr RM, Mursi NM.
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [Abstract] [Full Text] [Related]

  • 6. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA, Tripathi R, Mishra B.
    AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
    [Abstract] [Full Text] [Related]

  • 7. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL, Li P, Li YM.
    Pharm Dev Technol; 2012 Dec; 17(6):666-76. PubMed ID: 21486184
    [Abstract] [Full Text] [Related]

  • 8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
    Nokhodchi A, Momin MN, Shokri J, Shahsavari M, Rashidi PA.
    Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of polyvinylpyrrolidone both as a binder and pore-former on the release of sparingly water-soluble topiramate from ethylcellulose coated pellets.
    Yang M, Xie S, Li Q, Wang Y, Chang X, Shan L, Sun L, Huang X, Gao C.
    Int J Pharm; 2014 Apr 25; 465(1-2):187-96. PubMed ID: 24530810
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT.
    Eur J Pharm Biopharm; 2008 Sep 25; 70(1):289-301. PubMed ID: 18539015
    [Abstract] [Full Text] [Related]

  • 14. Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.
    Ali J, Tyagi P, Ahuja A, Baboota S, Hasan S.
    PDA J Pharm Sci Technol; 2007 Sep 25; 61(2):88-96. PubMed ID: 17479716
    [Abstract] [Full Text] [Related]

  • 15. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D, Sharma R, Jain D.
    Pak J Pharm Sci; 2013 Jan 25; 26(1):137-44. PubMed ID: 23261739
    [Abstract] [Full Text] [Related]

  • 16. Controlled porosity osmotic pumps of highly aqueous soluble drug containing hydrophilic polymers as release retardants.
    Prabakaran D, Singh P, Kanaujia P, Mishra V, Jaganathan KS, Vyas SP.
    Pharm Dev Technol; 2004 Nov 25; 9(4):435-42. PubMed ID: 15581079
    [Abstract] [Full Text] [Related]

  • 17. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E, Cho W, Cha KH, Park J, Kim MS, Kim JS, Park HJ, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):91-8. PubMed ID: 20558265
    [Abstract] [Full Text] [Related]

  • 18. Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.
    Kushare SS, Gattani SG.
    J Pharm Pharmacol; 2013 Jan 30; 65(1):79-93. PubMed ID: 23215691
    [Abstract] [Full Text] [Related]

  • 19. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D, Survase S, Kumar N.
    Int J Pharm; 2011 Oct 31; 419(1-2):121-30. PubMed ID: 21807081
    [Abstract] [Full Text] [Related]

  • 20. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M, Newton M, Booth S, Clarke A.
    Eur J Pharm Biopharm; 2007 Jan 31; 65(1):94-8. PubMed ID: 17056237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.